Health Condition 1: R99- Ill-defined and unknown cause of mortality Health Condition 2: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For cases: Newly diagnosed and histopathologically confirmed cases of invasive ductal carcinoma of breast (IDC); no special type (NST) in female patients presenting with palpable breast lump. For controls: Diseased women brought in for postmortem examination with no past history of breast cancer.
Exclusion criteria
Exclusion criteria: For cases: 1. Patients who have received radiotherapy, chemotherapy and/or immunotherapy 2. Former history of breast cancer or any other types of cancer For controls: 1. Decomposed/ decayed body 2. Former history of breast cancer or any other types of cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of expression of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism in case and control populationTimepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of expression of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism in breast cancer patients and their association with histological grade and proliferation indexTimepoint: Baseline | — |
Countries
India
Contacts
Maulana Azad Medical College